AppLovin is a top investment pick with strong growth potential, value pricing, and likely 30% returns. See why APP is one of ...

Bristol-Myers Squibb sees stabilizing sales, growth in key drugs, and raised guidance. Click to read more about why BMY is an ...

M&A activity in the cybersecurity sector is on pace to exceed 2024 volume by 10% in 2025, with continued consolidation as ...